 |
Trials |
A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid TumorsCancer type: Kidney Phase: II Principal Investigator: Haug Åse Country: NO Keywords: Norway, Bergen, Eisai Hope Status: Inclusion completed Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02501096?term=eisai+hope&rank=7 |